
Teladoc Health Inc (NYSE:TDOC) shares are rising Monday after Citron Research made positive comments about the company on its X account.
What Happened: Citron posted on X Monday morning that it believes Teladoc stock is a “coiled spring,” trading at a $1.2 billion valuation.